The sponsor is an individual, company, institution, or organization that takes responsibility for the initiation, management, and financing of a clinical trial. Under ICH E6 Section 5, sponsors bear the ultimate responsibility for ensuring that their trials comply with GCP and applicable regulatory requirements.
What Are Sponsor Responsibilities?
The sponsor is responsible for selecting qualified investigators, providing them with the investigator’s brochure and approved protocol, and ensuring adequate trial monitoring and quality assurance. Sponsors must implement a risk-based monitoring approach and maintain oversight of all trial-related activities, including data management, adverse event reporting, and investigational product manufacturing and labeling. Sponsors may delegate certain duties to a Contract Research Organization (CRO), but ultimate responsibility remains with the sponsor.
Regulatory Framework
ICH E6 Section 5 comprehensively defines sponsor obligations, including quality management, resource allocation, and record retention. In the United States, 21 CFR Part 312 governs sponsor responsibilities, while the EU Clinical Trials Regulation (536/2014) sets equivalent standards for trials conducted in Europe. Sponsors are also subject to GCP inspection by regulatory authorities to verify compliance.
Key Requirements
Sponsors must develop a clinical trial protocol and ensure all amendments are reviewed and approved by relevant ethics committees and regulatory authorities before implementation. They must provide insurance or indemnity coverage for trial subjects and ensure that informed consent documents are appropriate and approved. Sponsors are also required to establish Data Safety Monitoring Boards (DSMBs) for certain high-risk or large-scale trials.
Documentation
The sponsor is responsible for compiling and maintaining the Trial Master File (TMF) as specified in ICH E6 Section 8. This includes the protocol and amendments, investigator’s brochure, regulatory approvals, monitoring visit reports, and financial disclosure information. All sponsor records must be retained for at least two years after the last marketing application approval or discontinuation of the investigational product.
Conclusion
Sponsor responsibilities span the entire clinical trial lifecycle from design to close-out. Effective oversight, robust quality management, and diligent documentation are essential for regulatory compliance. Sponsors must remain actively engaged in trial oversight even when delegating operational tasks to CROs.
